204 related articles for article (PubMed ID: 23117549)
1. Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5'-monophosphate dehydrogenase II (IMPDH II) inhibitors.
Dunkern T; Prabhu A; Kharkar PS; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Comput Aided Mol Des; 2012 Nov; 26(11):1277-92. PubMed ID: 23117549
[TBL] [Abstract][Full Text] [Related]
2. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
3. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
4. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
Cuny GD; Suebsuwong C; Ray SS
Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP.
Ji Y; Gu J; Makhov AM; Griffith JD; Mitchell BS
J Biol Chem; 2006 Jan; 281(1):206-12. PubMed ID: 16243838
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
9. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
10. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
11. A novel series of non-nucleoside inhibitors of inosine 5'-monophosphate dehydrogenase with immunosuppressive activity.
Franklin TJ; Morris WP; Jacobs VN; Culbert EJ; Heys CA; Ward WH; Cook PN; Jung F; Plé P
Biochem Pharmacol; 1999 Sep; 58(5):867-76. PubMed ID: 10449198
[TBL] [Abstract][Full Text] [Related]
12. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
Prosise GL; Wu JZ; Luecke H
J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
[TBL] [Abstract][Full Text] [Related]
15. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
Fotie J
Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
[TBL] [Abstract][Full Text] [Related]
18. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
19. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
20. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
Liu FY; Qiu XY; Jiao Z
Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]